Emmaus Life Sciences, Inc. Registration of securities issued in business combination transactions

Registration of securities issued in business combination transactions

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
Notes Tables
Notes Details

SIGNIFICANT CUSTOMERS

SIGNIFICANT CUSTOMERS	12 Months Ended
Sep. 30, 2018
Significant Customers
SIGNIFICANT CUSTOMERS	12. SIGNIFICANT CUSTOMERS For the fiscal year ended September 30, 2018, four customers accounted for 29% of Neurometric Services revenue and three customers accounted for 35% of accounts receivable at September 30, 2018. For the fiscal year ended September 30, 2017, four customers accounted for 50% of Neurometric Services revenue and three customers accounted for 72% of accounts receivable at September 30, 2017.

SIGNIFICANT CUSTOMERS

12 Months Ended

Sep. 30, 2018

Significant Customers

SIGNIFICANT CUSTOMERS

12. SIGNIFICANT CUSTOMERS

For the fiscal year ended September 30, 2018, four customers accounted for 29% of Neurometric Services revenue and three customers accounted for 35% of accounts receivable at September 30, 2018.

For the fiscal year ended September 30, 2017, four customers accounted for 50% of Neurometric Services revenue and three customers accounted for 72% of accounts receivable at September 30, 2017.